Literature DB >> 26655447

Statins and the brain: New perspective for old drugs.

Q Ling1, M V Tejada-Simon2.   

Abstract

Statins are one of the most popular lipid-lowering drugs (LLDs). Upon oral administration, these drugs are well absorbed by the intestine and effectively used for the treatment of dyslipidemias. Recently, statins are becoming also well-known for their cholesterol-independent effects and their potential use in brain diseases and different types of cancers. While still controversial, recent research has suggested that statin's cholesterol-independent activities work possibly through alterations on isoprenoid levels. This reduction of isoprenoids in the central nervous system might result in effective biochemical and behavioral improvements on certain neurological disorders. This manuscript aims to highlight current research describing the use of statin therapy in the brain and discuss whether statins might affect neuronal dynamics and function independently of their cholesterol regulatory role.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Autism; Cholesterol; Cognition; Neurodegenerative disorders; Statin

Mesh:

Substances:

Year:  2015        PMID: 26655447     DOI: 10.1016/j.pnpbp.2015.11.013

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  11 in total

1.  Cholesterol intake and statin use regulate neuronal G protein-gated inwardly rectifying potassium channels.

Authors:  Anna N Bukiya; Paul S Blank; Avia Rosenhouse-Dantsker
Journal:  J Lipid Res       Date:  2018-11-12       Impact factor: 5.922

2.  Increased Training Intensity Induces Proper Membrane Localization of Actin Remodeling Proteins in the Hippocampus Preventing Cognitive Deficits: Implications for Fragile X Syndrome.

Authors:  L A Martinez; Maria Victoria Tejada-Simon
Journal:  Mol Neurobiol       Date:  2017-07-08       Impact factor: 5.590

Review 3.  The beneficial effects of HMG-CoA reductase inhibitors in the processes of neurodegeneration.

Authors:  Seyed Soheil Saeedi Saravi; Seyed Sobhan Saeedi Saravi; Alireza Arefidoust; Ahmad Reza Dehpour
Journal:  Metab Brain Dis       Date:  2017-06-03       Impact factor: 3.584

4.  Identification and characterization of prescription drugs that change levels of 7-dehydrocholesterol and desmosterol.

Authors:  Phillip A Wages; Hye-Young H Kim; Zeljka Korade; Ned A Porter
Journal:  J Lipid Res       Date:  2018-08-07       Impact factor: 5.922

5.  Association between Statin Use and Sepsis Risk in Patients with Dementia: A Retrospective Cohort Study.

Authors:  Liang-Tsai Yeh; Chuan-Yi Tang; Shun-Fa Yang; Han-Wei Yeh; Ying-Tung Yeh; Yu-Hsun Wang; Ming-Chih Chou; Chao-Bin Yeh; Chi-Ho Chan
Journal:  Int J Environ Res Public Health       Date:  2019-05-09       Impact factor: 3.390

6.  Lovastatin, not Simvastatin, Corrects Core Phenotypes in the Fragile X Mouse Model.

Authors:  Melania Muscas; Susana R Louros; Emily K Osterweil
Journal:  eNeuro       Date:  2019-06-12

7.  Randomised controlled trial of simvastatin treatment for autism in young children with neurofibromatosis type 1 (SANTA).

Authors:  Stavros Stivaros; Shruti Garg; Jonathan Green; Maria Tziraki; Ying Cai; Owen Thomas; Joseph Mellor; Andrew A Morris; Carly Jim; Karolina Szumanska-Ryt; Laura M Parkes; Hamied A Haroon; Daniela Montaldi; Nicholas Webb; John Keane; Francisco X Castellanos; Alcino J Silva; Sue Huson; Stephen Williams; D Gareth Evans; Richard Emsley
Journal:  Mol Autism       Date:  2018-02-22       Impact factor: 7.509

8.  A Differential Effect of Lovastatin versus Simvastatin in Neurodevelopmental Disorders.

Authors:  Melania Muscas; Sang S Seo; Susana R Louros; Emily K Osterweil
Journal:  eNeuro       Date:  2020-08-13

Review 9.  Update on Statin Treatment in Patients with Neuropsychiatric Disorders.

Authors:  Razieh Avan; Adeleh Sahebnasagh; Javad Hashemi; Mahila Monajati; Fatemeh Faramarzi; Neil C Henney; Fabrizio Montecucco; Tannaz Jamialahmadi; Amirhossein Sahebkar
Journal:  Life (Basel)       Date:  2021-12-08

10.  Structure and Fate of Nanoparticles Designed for the Nasal Delivery of Poorly Soluble Drugs.

Authors:  Adryana Rocha Clementino; Giulia Pellegrini; Sabrina Banella; Gaia Colombo; Laura Cantù; Fabio Sonvico; Elena Del Favero
Journal:  Mol Pharm       Date:  2021-07-14       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.